The Relative Strength (RS) Rating for Sotera Health moved up into a higher percentile Monday, as it got a lift from 65 to 71.
IBD's proprietary RS Rating identifies market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Over 100 years of market history reveals that the best stocks often have an RS Rating north of 80 in the early stages of their moves. See if Sotera Health can continue to rebound and hit that benchmark.
Can You Really Time The Stock Market?
Sotera Health is trying to complete a cup with handle with a 17.08 buy point. See if it can break out in volume at least 40% higher than normal.
Sotera Health reported 6% earnings growth in its most recent report. Sales increased 8%.
The company earns the No. 6 rank among its peers in the Medical-Services industry group. Hims & Hers Health, Guardian Pharmacy Svcs and Castle Biosciences are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
